BSE filing, NSE: MERCURYLAB. Summary written from the filing by ALFA Finder's alert engine.
Mercury Laboratories Ltd: key numbers
- Share price
- ₹733.05
- Market cap
- ₹87.97 Cr
- Revenue (annual)
- ₹75.94 Cr
- Net profit (annual)
- ₹4.83 Cr
- P/E (TTM)
- 21.1×Sector 46.1×
- Promoter holding
- 73.66%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mercury Laboratories Ltd
All →Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Mercury Laboratories Management Change
Mercury Laboratories disclosed the cessation of Manager-HR Jaydeepsinh Raj, effective October 28, 2026. The employee stopped reporting for duty without prior intimation to the company.
Mercury Laboratories Other Announcement
Mercury Laboratories Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b). The report provides a standard breakdown of the company's current equity ownership structure.
Mercury Laboratories Management Change
Mr. Dilip Ramanlal Shah has ceased to be a Non-Executive Director of Mercury Laboratories Limited following the non-approval of his re-appointment at the recent AGM.
Mercury Laboratories Annual General Meeting
Mercury Laboratories Limited conducted its 45th Annual General Meeting on September 28, 2026. Shareholders considered agenda items including financial statements adoption and a ₹3.50 per share dividend.
Mercury Laboratories Management Change
Mercury Laboratories has appointed Mr. Jaydeepsinh Raj as Manager-HR, effective September 03, 2026.
Other board meeting date announcements
All →Jenburkt Pharmaceuticals Board Meeting Date
Jenburkt Pharmaceuticals has intimated that its Board will meet on 3 Nov 2026 to consider Q2/H1-26 financial results. No decision has been taken yet.
Kingfa Science & Technology (India) Board Meeting Date
Kingfa informed exchanges its Board meeting is scheduled for November 5, 2026, to consider Q1/H1 FY27 unaudited results. Trading window stays closed until 48 hours post-announcement.
Orient Press Board Meeting Date
Orient Press Ltd intimated its Board meeting is scheduled for 05/11/2026, inter alia to approve unaudited Q3 FY27 results. The trading window stays closed till 48 hours after the intimation on 07/11/2026.
Surya Roshni Board Meeting Date
Surya Roshni's board will meet on November 7, 2026, to approve Q2 FY27 unaudited results. Trading window stays closed until November 9.
Prerna Infrabuild Board Meeting Date
Prerna Infrabuild will convene its board on 04/11/2026 to consider quarter results. The meeting is proposed under Regulation 33 of the LODR.
JSL Industries Board Meeting Date
JSL Industries intimates that its Board will meet on 5 Nov 2026 to consider unaudited Q1/H1 results. The trading window closes from 1 Oct 2026 until results are public.